{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:04:23Z","timestamp":1790049863523,"version":"4.0.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73380-x","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:14:57Z","timestamp":1779513297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Jessica E.","family":"Gianopulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6585-4308","authenticated-orcid":false,"given":"Aidan","family":"Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6633-4228","authenticated-orcid":false,"given":"Stephanie","family":"Dobersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-5892","authenticated-orcid":false,"given":"Adrianne","family":"Wallace-Povirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-7584","authenticated-orcid":false,"given":"Sophie E.","family":"Kogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2255-8905","authenticated-orcid":false,"given":"Pritha","family":"Chanana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-753X","authenticated-orcid":false,"given":"Sabrina","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mangino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberalis D.","family":"Boila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Padilla-Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-5136","authenticated-orcid":false,"given":"Nicole","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-9884","authenticated-orcid":false,"given":"Robert J.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-933X","authenticated-orcid":false,"given":"Kevin J.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-5019","authenticated-orcid":false,"given":"Daniel","family":"Blanco-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiyaz","family":"Notta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-187X","authenticated-orcid":false,"given":"Sita","family":"Kugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"73380_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74, 2913\u20132921 (2014).","journal-title":"Cancer Res"},{"key":"73380_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"73380_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469\u2013483 (2005).","journal-title":"Cancer Cell"},{"key":"73380_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41416-019-0507-5","volume":"121","author":"G Brar","year":"2019","unstructured":"Brar, G. et al. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. Br. J. Cancer 121, 264\u2013270 (2019).","journal-title":"Br. J. Cancer"},{"key":"73380_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"73380_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"73380_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"73380_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"BJ Raphael","year":"2017","unstructured":"Raphael, B. J. et al. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185\u2013203.e13 (2017).","journal-title":"Cancer Cell"},{"key":"73380_CR9","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F. et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155, 1999\u20132013.e3 (2018).","journal-title":"Gastroenterology"},{"key":"73380_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A. et al. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat. Cancer 1, 59\u201374 (2020).","journal-title":"Nat. Cancer"},{"key":"73380_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet. 52, 231\u2013240 (2020).","journal-title":"Nat. Genet."},{"key":"73380_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04383-6","volume":"9","author":"G Lomberk","year":"2018","unstructured":"Lomberk, G. et al. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes. Nat. Commun. 9, 1978 (2018).","journal-title":"Nat. Commun."},{"key":"73380_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11812-7","volume":"10","author":"G Lomberk","year":"2019","unstructured":"Lomberk, G., Dusetti, N., Iovanna, J. & Urrutia, R. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine. Nat. Commun. 10, 3875 (2019).","journal-title":"Nat. Commun."},{"key":"73380_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"73380_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/0008-5472.CAN-23-1067","volume":"84","author":"A Mehta","year":"2024","unstructured":"Mehta, A. & Stanger, B. Z. Lineage plasticity: The new cancer hallmark on the block. Cancer Res. 84, 184 (2024).","journal-title":"Cancer Res."},{"key":"73380_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/15592294.2016.1169351","volume":"11","author":"D Valle-Garc\u00eda","year":"2016","unstructured":"Valle-Garc\u00eda, D. et al. ATRX binds to atypical chromatin domains at the 3\u2032 exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics 11, 398\u2013414 (2016).","journal-title":"Epigenetics"},{"key":"73380_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015082","volume":"5","author":"S Frietze","year":"2010","unstructured":"Frietze, S., O\u2019Geen, H., Blahnik, K. R., Jin, V. X. & Farnham, P. J. ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3\u2032 Ends of ZNF Genes. PLOS ONE 5, e15082 (2010).","journal-title":"PLOS ONE"},{"key":"73380_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado1662","volume":"10","author":"M Begnis","year":"2024","unstructured":"Begnis, M. et al. Clusters of lineage-specific genes are anchored by ZNF274 in repressive perinucleolar compartments. Sci. Adv. 10, eado1662 (2024).","journal-title":"Sci. Adv."},{"key":"73380_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860\u2013921 (2001).","journal-title":"Nature"},{"key":"73380_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/35057011","volume":"409","author":"R Tupler","year":"2001","unstructured":"Tupler, R., Perini, G. & Green, M. R. Expressing the human genome. Nature 409, 832\u2013833 (2001).","journal-title":"Nature"},{"key":"73380_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1101\/gr.963903","volume":"13","author":"M Shannon","year":"2003","unstructured":"Shannon, M., Hamilton, A. T., Gordon, L., Branscomb, E. & Stubbs, L. Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters. Genome Res 13, 1097\u20131110 (2003).","journal-title":"Genome Res"},{"key":"73380_CR22","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/molbev\/msh246","volume":"21","author":"D Schmidt","year":"2004","unstructured":"Schmidt, D. & Durrett, R. Adaptive evolution drives the diversification of zinc-finger binding domains. Mol. Biol. Evol. 21, 2326\u20132339 (2004).","journal-title":"Mol. Biol. Evol."},{"key":"73380_CR23","doi-asserted-by":"publisher","first-page":"e1000325","DOI":"10.1371\/journal.pgen.1000325","volume":"5","author":"RO Emerson","year":"2009","unstructured":"Emerson, R. O. & Thomas, J. H. Adaptive evolution in zinc finger transcription factors. PLOS Genet 5, e1000325 (2009).","journal-title":"PLOS Genet"},{"key":"73380_CR24","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1101\/gr.121749.111","volume":"21","author":"JH Thomas","year":"2011","unstructured":"Thomas, J. H. & Schneider, S. Coevolution of retroelements and tandem zinc finger genes. Genome Res 21, 1800\u20131812 (2011).","journal-title":"Genome Res"},{"key":"73380_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature13760","volume":"516","author":"FMJ Jacobs","year":"2014","unstructured":"Jacobs, F. M. J. et al. An evolutionary arms race between KRAB zinc-finger genes ZNF91\/93 and SVA\/L1 retrotransposons. Nature 516, 242\u2013245 (2014).","journal-title":"Nature"},{"key":"73380_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature02399","volume":"428","author":"J Grimwood","year":"2004","unstructured":"Grimwood, J. et al. The DNA sequence and biology of human chromosome 19. Nature 428, 529\u2013535 (2004).","journal-title":"Nature"},{"key":"73380_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2013.150","volume":"21","author":"S Lukic","year":"2014","unstructured":"Lukic, S., Nicolas, J.-C. & Levine, A. J. The diversity of zinc-finger genes on human chromosome 19 provides an evolutionary mechanism for defense against inherited endogenous retroviruses. Cell Death Differ. 21, 381\u2013387 (2014).","journal-title":"Cell Death Differ."},{"key":"73380_CR28","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1242\/dev.132605","volume":"144","author":"G Ecco","year":"2017","unstructured":"Ecco, G., Imbeault, M. & Trono, D. KRAB zinc finger proteins. Development 144, 2719\u20132729 (2017).","journal-title":"Development"},{"key":"73380_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1101\/gad.973302","volume":"16","author":"DC Schultz","year":"2002","unstructured":"Schultz, D. C., Ayyanathan, K., Negorev, D., Maul, G. G. & Rauscher, F. J. SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16, 919\u2013932 (2002).","journal-title":"Genes Dev."},{"key":"73380_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10577-016-9547-3","volume":"25","author":"G Nishibuchi","year":"2017","unstructured":"Nishibuchi, G. & D\u00e9jardin, J. The molecular basis of the organization of repetitive DNA-containing constitutive heterochromatin in mammals. Chromosome Res 25, 77\u201387 (2017).","journal-title":"Chromosome Res"},{"key":"73380_CR31","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1128\/MCB.01331-10","volume":"31","author":"S Iyengar","year":"2011","unstructured":"Iyengar, S., Ivanov, A. V., Jin, V. X., Rauscher, F. J. & Farnham, P. J. Functional analysis of KAP1 genomic recruitment. Mol. Cell. Biol. 31, 1833\u20131847 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"73380_CR32","doi-asserted-by":"publisher","first-page":"26267","DOI":"10.1074\/jbc.R111.252569","volume":"286","author":"S Iyengar","year":"2011","unstructured":"Iyengar, S. & Farnham, P. J. KAP1 protein: An enigmatic master regulator of the genome*. J. Biol. Chem. 286, 26267\u201326276 (2011).","journal-title":"J. Biol. Chem."},{"key":"73380_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","volume":"23","author":"J Jen","year":"2016","unstructured":"Jen, J. & Wang, Y.-C. Zinc finger proteins in cancer progression. J. Biomed. Sci. 23, 53 (2016).","journal-title":"J. Biomed. Sci."},{"key":"73380_CR34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300801R","volume":"37","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Wen, D., Zhang, S., Jiang, H. & Di, X. The role of zinc finger proteins in malignant tumors. FASEB J. 37, e23157 (2023).","journal-title":"FASEB J."},{"key":"73380_CR35","doi-asserted-by":"publisher","first-page":"10249","DOI":"10.3390\/ijms241210249","volume":"24","author":"AS Iyer","year":"2023","unstructured":"Iyer, A. S., Shaik, M. R., Raufman, J.-P. & Xie, G. The roles of zinc finger proteins in colorectal cancer. Int. J. Mol. Sci. 24, 10249 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"73380_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10565-021-09582-4","volume":"37","author":"S Bhat","year":"2021","unstructured":"Bhat, S. et al. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer. Cell Biol. Toxicol. 37, 731\u2013749 (2021).","journal-title":"Cell Biol. Toxicol."},{"key":"73380_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/gutjnl-2011-301776","volume":"62","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut 62, 833\u2013841 (2013).","journal-title":"Gut"},{"key":"73380_CR38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bab.1790","volume":"66","author":"M Marzbany","year":"2019","unstructured":"Marzbany, M., Bishayee, A. & Rasekhian, M. Increased expression of ZNF 703 in breast cancer tissue: An opportunity for RNAi\u2013NSAID combinatorial therapy. Biotechnol. Appl. Biochem. 66, 808\u2013814 (2019).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"73380_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1158\/1078-0432.CCR-17-2180","volume":"24","author":"A Muckenhuber","year":"2018","unstructured":"Muckenhuber, A. et al. Pancreatic ductal adenocarcinoma subtyping using the biomarkers hepatocyte nuclear factor-1A and cytokeratin-81 correlates with outcome and treatment response. Clin. Cancer Res. 24, 351\u2013359 (2018).","journal-title":"Clin. Cancer Res."},{"key":"73380_CR40","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.celrep.2018.10.051","volume":"25","author":"TDD Somerville","year":"2018","unstructured":"Somerville, T. D. D. et al. TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma. Cell Rep. 25, 1741\u20131755.e7 (2018).","journal-title":"Cell Rep."},{"key":"73380_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47519-4","volume":"9","author":"L Roa-Pe\u00f1a","year":"2019","unstructured":"Roa-Pe\u00f1a, L. et al. Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Sci. Rep. 9, 11239 (2019).","journal-title":"Sci. Rep."},{"key":"73380_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","volume":"3","author":"AN Hosein","year":"2022","unstructured":"Hosein, A. N., Dougan, S. K., Aguirre, A. J. & Maitra, A. Translational advances in pancreatic ductal adenocarcinoma therapy. Nat. Cancer 3, 272\u2013286 (2022).","journal-title":"Nat. Cancer"},{"key":"73380_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94544-3","volume":"11","author":"K Duan","year":"2021","unstructured":"Duan, K. et al. The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer. Sci. Rep. 11, 14951 (2021).","journal-title":"Sci. Rep."},{"key":"73380_CR44","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1200\/JCO.2024.42.16_suppl.4150","volume":"42","author":"RA Mc Laughlin","year":"2024","unstructured":"Mc Laughlin, R. A. et al. GATA6 expression in advanced pancreatic ductal adenocarcinoma (PDAC) as a prognostic and predictive biomarker in the Canadian COMPASS trial and the Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS. J. Clin. Oncol. 42, 4150\u20134150 (2024).","journal-title":"J. Clin. Oncol."},{"key":"73380_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"73380_CR46","doi-asserted-by":"publisher","first-page":"901038","DOI":"10.3389\/fcell.2022.901038","volume":"10","author":"S Yoon","year":"2022","unstructured":"Yoon, S. et al. Combining image restoration and traction force microscopy to study extracellular matrix-dependent keratin filament network plasticity. Front. Cell Dev. Biol. 10, 901038 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"73380_CR47","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jid.2019.03.1139","volume":"139","author":"A Pora","year":"2019","unstructured":"Pora, A., Yoon, S., Windoffer, R. & Leube, R. E. Hemidesmosomes and Focal Adhesions Treadmill as Separate but Linked Entities during Keratinocyte Migration. J. Invest. Dermatol. 139, 1876\u20131888.e4 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"73380_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01982-0","volume":"21","author":"W Yin","year":"2021","unstructured":"Yin, W. et al. Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell Int 21, 276 (2021).","journal-title":"Cancer Cell Int"},{"key":"73380_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.matbio.2009.12.003","volume":"29","author":"D Medici","year":"2009","unstructured":"Medici, D. & Nawshad, A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-\u03baB and LEF-1. Matrix Biol. J. Int. Soc. Matrix Biol. 29, 161 (2009).","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"73380_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29857-6","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. Nat. Commun. 13, 2169 (2022).","journal-title":"Nat. Commun."},{"key":"73380_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/epigenomes5040020","volume":"5","author":"JK Thompson","year":"2021","unstructured":"Thompson, J. K. & Bednar, F. Clinical utility of epigenetic changes in pancreatic adenocarcinoma. Epigenomes 5, 20 (2021).","journal-title":"Epigenomes"},{"key":"73380_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gde.2021.10.001","volume":"72","author":"BH Lee","year":"2022","unstructured":"Lee, B. H., Seijo-Barandiaran, I. & Grapin-Botton, A. Epithelial morphogenesis in organoids. Curr. Opin. Genet. Dev. 72, 30\u201337 (2022).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"73380_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ydbio.2011.12.041","volume":"366","author":"E Theveneau","year":"2012","unstructured":"Theveneau, E. & Mayor, R. Neural crest delamination and migration: From epithelium-to-mesenchyme transition to collective cell migration. Dev. Biol. 366, 34\u201354 (2012).","journal-title":"Dev. Biol."},{"key":"73380_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15548-7","volume":"11","author":"JM Rosenbluth","year":"2020","unstructured":"Rosenbluth, J. M. et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat. Commun. 11, 1711 (2020).","journal-title":"Nat. Commun."},{"key":"73380_CR55","doi-asserted-by":"publisher","first-page":"a041661","DOI":"10.1101\/cshperspect.a041661","volume":"14","author":"SK Muthuswamy","year":"2024","unstructured":"Muthuswamy, S. K. & Brugge, J. S. Organoid cultures for the study of mammary biology and breast cancer: The promise and challenges. Cold Spring Harb. Perspect. Med. 14, a041661 (2024).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"73380_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/embj.201592404","volume":"35","author":"GR Diaferia","year":"2016","unstructured":"Diaferia, G. R. et al. Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer. EMBO J. 35, 595\u2013617 (2016).","journal-title":"EMBO J."},{"key":"73380_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","volume":"14","author":"P Zhang","year":"2015","unstructured":"Zhang, P., Sun, Y. & Ma, L. Z. E. B. 1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 14, 481 (2015).","journal-title":"Cell Cycle"},{"key":"73380_CR58","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/onc.2010.102","volume":"29","author":"E S\u00e1nchez-Till\u00f3","year":"2010","unstructured":"S\u00e1nchez-Till\u00f3, E. et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1. Oncogene 29, 3490\u20133500 (2010).","journal-title":"Oncogene"},{"key":"73380_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2340-4","volume":"11","author":"P Lindner","year":"2020","unstructured":"Lindner, P. et al. EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells. Cell Death Dis. 11, 1\u201313 (2020).","journal-title":"Cell Death Dis."},{"key":"73380_CR60","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518\u2013529 (2017).","journal-title":"Nat. Cell Biol."},{"key":"73380_CR61","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","volume":"160","author":"M Liu","year":"2021","unstructured":"Liu, M. et al. Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology 160, 1771\u20131783.e1 (2021).","journal-title":"Gastroenterology"},{"key":"73380_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00109-023-02294-8","volume":"101","author":"A Klonou","year":"2023","unstructured":"Klonou, A. et al. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis. J. Mol. Med. 101, 387\u2013401 (2023).","journal-title":"J. Mol. Med."},{"key":"73380_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15252\/embr.201744250","volume":"19","author":"D Du","year":"2018","unstructured":"Du, D. et al. Smad3-mediated recruitment of the methyltransferase SETDB1\/ESET controls Snail1 expression and epithelial\u2013mesenchymal transition. EMBO Rep. 19, 135\u2013155 (2018).","journal-title":"EMBO Rep."},{"key":"73380_CR64","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2016-01-694810","volume":"128","author":"S Koide","year":"2016","unstructured":"Koide, S. et al. Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes. Blood 128, 638\u2013649 (2016).","journal-title":"Blood"},{"key":"73380_CR65","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1073\/pnas.0401866101","volume":"101","author":"G Liang","year":"2004","unstructured":"Liang, G. et al. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc. Natl. Acad. Sci. 101, 7357\u20137362 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"73380_CR66","doi-asserted-by":"publisher","first-page":"e103209","DOI":"10.15252\/embj.2019103209","volume":"39","author":"N Feldker","year":"2020","unstructured":"Feldker, N. et al. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer. EMBO J. 39, e103209 (2020).","journal-title":"EMBO J."},{"key":"73380_CR67","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/2159-8290.CD-20-1202","volume":"11","author":"E Espinet","year":"2021","unstructured":"Espinet, E. et al. Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell of origin. Cancer Discov. 11, 638\u2013659 (2021).","journal-title":"Cancer Discov."},{"key":"73380_CR68","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","volume":"187","author":"E You","year":"2024","unstructured":"You, E. et al. Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer. Cell 187, 7232\u20137247 (2024).","journal-title":"Cell"},{"key":"73380_CR69","doi-asserted-by":"crossref","unstructured":"Sun, S. et al. Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms. Immunity 57, 2879\u20132894.e11 (2024).","DOI":"10.1016\/j.immuni.2024.10.015"},{"key":"73380_CR70","doi-asserted-by":"publisher","first-page":"110236","DOI":"10.1016\/j.celrep.2021.110236","volume":"38","author":"ER Abt","year":"2022","unstructured":"Abt, E. R. et al. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells. Cell Rep. 38, 110236 (2022).","journal-title":"Cell Rep."},{"key":"73380_CR71","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162, 974\u2013986 (2015).","journal-title":"Cell"},{"key":"73380_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl6173","volume":"385","author":"M-J Wu","year":"2024","unstructured":"Wu, M.-J. et al. Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science 385, eadl6173 (2024).","journal-title":"Science"},{"key":"73380_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ncrna7010015","volume":"7","author":"S Sadeq","year":"2021","unstructured":"Sadeq, S., Al-Hashimi, S., Cusack, C. M. & Werner, A. Endogenous double-stranded RNA. Non-Coding RNA 7, 15 (2021).","journal-title":"Non-Coding RNA"},{"key":"73380_CR74","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","volume":"23","author":"YG Chen","year":"2022","unstructured":"Chen, Y. G. & Hur, S. Cellular origins of dsRNA, their recognition and consequences. Nat. Rev. Mol. Cell Biol. 23, 286\u2013301 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"73380_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41577-023-00940-3","volume":"24","author":"R de Reuver","year":"2024","unstructured":"de Reuver, R. & Maelfait, J. Novel insights into double-stranded RNA-mediated immunopathology. Nat. Rev. Immunol. 24, 235\u2013249 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"73380_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn9674","volume":"15","author":"N Kartha","year":"2023","unstructured":"Kartha, N. et al. Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases. Sci. Transl. Med. 15, eabn9674 (2023).","journal-title":"Sci. Transl. Med."},{"key":"73380_CR77","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41388-022-02347-1","volume":"41","author":"TA Constantin","year":"2022","unstructured":"Constantin, T. A., Greenland, K. K., Varela-Carver, A. & Bevan, C. L. Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer. Oncogene 41, 3303\u20133315 (2022).","journal-title":"Oncogene"},{"key":"73380_CR78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/21541264.2018.1539615","volume":"10","author":"MD Galbraith","year":"2018","unstructured":"Galbraith, M. D., Bender, H. & Espinosa, J. M. Therapeutic targeting of transcriptional cyclin-dependent kinases. Transcription 10, 118\u2013136 (2018).","journal-title":"Transcription"},{"key":"73380_CR79","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","volume":"511","author":"N Kwiatkowski","year":"2014","unstructured":"Kwiatkowski, N. et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 511, 616\u2013620 (2014).","journal-title":"Nature"},{"key":"73380_CR80","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.chembiol.2019.02.012","volume":"26","author":"CM Olson","year":"2019","unstructured":"Olson, C. M. et al. Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype. Cell Chem. Biol. 26, 792\u2013803.e10 (2019).","journal-title":"Cell Chem. Biol."},{"key":"73380_CR81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","volume":"163","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell 163, 174\u2013186 (2015).","journal-title":"Cell"},{"key":"73380_CR82","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","volume":"26","author":"CL Christensen","year":"2014","unstructured":"Christensen, C. L. et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26, 909\u2013922 (2014).","journal-title":"Cancer Cell"},{"key":"73380_CR83","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","volume":"159","author":"E Chipumuro","year":"2014","unstructured":"Chipumuro, E. et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159, 1126\u20131139 (2014).","journal-title":"Cell"},{"key":"73380_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccell.2019.11.003","volume":"37","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer. Cancer Cell 37, 37\u201354.e9 (2020).","journal-title":"Cancer Cell"},{"key":"73380_CR85","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1021\/acs.jmedchem.1c01171","volume":"65","author":"JJ Marineau","year":"2022","unstructured":"Marineau, J. J. et al. Discovery of SY-5609: A selective, noncovalent inhibitor of CDK7. J. Med. Chem. 65, 1458\u20131480 (2022).","journal-title":"J. Med. Chem."},{"key":"73380_CR86","doi-asserted-by":"publisher","first-page":"S587","DOI":"10.1016\/j.annonc.2021.08.1040","volume":"32","author":"M Sharma","year":"2021","unstructured":"Sharma, M. et al. 518MO tolerability and preliminary clinical activity of SY-5609, a highly potent and selective oral CDK7 inhibitor, in patients with advanced solid tumors. Ann. Oncol. 32, S587\u2013S588 (2021).","journal-title":"Ann. Oncol."},{"key":"73380_CR87","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1200\/JCO.2023.41.16_suppl.3080","volume":"41","author":"B Bashir","year":"2023","unstructured":"Bashir, B. et al. Phase 1\/1b study of SY-5609, a selective and potent CDK7 inhibitor, in advanced solid tumors and in 2L\/3L pancreatic ductal adenocarcinoma (PDAC) in combination with gemcitabine +\/- nab-paclitaxel. J. Clin. Oncol. 41, 3080\u20133080 (2023).","journal-title":"J. Clin. Oncol."},{"key":"73380_CR88","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"73380_CR89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1166\/ch.2013.1004","volume":"1","author":"Y Wang","year":"2013","unstructured":"Wang, Y. & Zhou, B. P. Epithelial-mesenchymal Transition-A Hallmark of Breast Cancer Metastasis. Cancer Hallm. 1, 38\u201349 (2013).","journal-title":"Cancer Hallm."},{"key":"73380_CR90","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1158\/0008-5472.CAN-19-0187","volume":"79","author":"C Mottini","year":"2019","unstructured":"Mottini, C. et al. Predictive signatures inform the effective repurposing of decitabine to treat KRAS\u2013dependent pancreatic ductal adenocarcinoma. Cancer Res 79, 5612\u20135625 (2019).","journal-title":"Cancer Res"},{"key":"73380_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01367-8","volume":"14","author":"TR Heumann","year":"2022","unstructured":"Heumann, T. R. et al. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Clin. Epigenetics 14, 166 (2022).","journal-title":"Clin. Epigenetics"},{"key":"73380_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0487-z","volume":"9","author":"L Gailhouste","year":"2018","unstructured":"Gailhouste, L., Liew, L. C., Hatada, I., Nakagama, H. & Ochiya, T. Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells. Cell Death Dis. 9, 1\u201312 (2018).","journal-title":"Cell Death Dis."},{"key":"73380_CR93","doi-asserted-by":"publisher","first-page":"104602","DOI":"10.1016\/j.ebiom.2023.104602","volume":"92","author":"NA Fraunhoffer","year":"2023","unstructured":"Fraunhoffer, N. A. et al. Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells. eBioMedicine 92, 104602 (2023).","journal-title":"eBioMedicine"},{"key":"73380_CR94","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","volume":"24","author":"KL Aung","year":"2018","unstructured":"Aung, K. L. et al. Genomics-driven precision medicine for advanced pancreatic cancer: Early results from the COMPASS trial. Clin. Cancer Res. J. Am. Assoc. Cancer Res. 24, 1344\u20131354 (2018).","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"73380_CR95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ccell.2018.12.010","volume":"35","author":"AA Connor","year":"2019","unstructured":"Connor, A. A. et al. Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases. Cancer Cell 35, 267\u2013282.e7 (2019).","journal-title":"Cancer Cell"},{"key":"73380_CR96","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamaoncol.2016.3916","volume":"3","author":"AA Connor","year":"2017","unstructured":"Connor, A. A. et al. Association of distinct mutational signatures with correlates of increased immune activity in pancreatic ductal adenocarcinoma. JAMA Oncol. 3, 774\u2013783 (2017).","journal-title":"JAMA Oncol."},{"key":"73380_CR97","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature19823","volume":"538","author":"F Notta","year":"2016","unstructured":"Notta, F. et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 378\u2013382 (2016).","journal-title":"Nature"},{"key":"73380_CR98","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","volume":"26","author":"GM O\u2019Kane","year":"2020","unstructured":"O\u2019Kane, G. M. et al. GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer. Clin. Cancer Res. 26, 4901\u20134910 (2020).","journal-title":"Clin. Cancer Res."},{"key":"73380_CR99","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","volume":"26","author":"NU Rashid","year":"2020","unstructured":"Rashid, N. U. et al. Purity independent subtyping of tumors (PurIST), a clinically robust, single sample classifier for tumor subtyping in pancreatic cancer. Clin. Cancer Res. J. Am. Assoc. Cancer Res. 26, 82\u201392 (2020).","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"73380_CR100","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan, A. B. et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 47, W212\u2013W224 (2019).","journal-title":"Nucleic Acids Res"},{"key":"73380_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"73380_CR102","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/nprot.2009.221","volume":"4","author":"KJ Bayless","year":"2009","unstructured":"Bayless, K. J., Kwak, H.-I. & Su, S.-C. Investigating endothelial invasion and sprouting behavior in three-dimensional collagen matrices. Nat. Protoc. 4, 1888\u20131898 (2009).","journal-title":"Nat. Protoc."},{"key":"73380_CR103","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","volume":"155","author":"KJ Cheung","year":"2013","unstructured":"Cheung, K. J., Gabrielson, E., Werb, Z. & Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639\u20131651 (2013).","journal-title":"Cell"},{"key":"73380_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15 (2012).","journal-title":"Bioinformatics"},{"key":"73380_CR105","unstructured":"Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"73380_CR106","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184\u20132185 (2012).","journal-title":"Bioinformatics"},{"key":"73380_CR107","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"73380_CR108","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/bioinformatics\/btv422","volume":"31","author":"Y Jin","year":"2015","unstructured":"Jin, Y., Tam, O. H., Paniagua, E. & Hammell, M. TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics 31, 3593\u20133599 (2015).","journal-title":"Bioinformatics"},{"key":"73380_CR109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"73380_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03258-y","volume":"25","author":"D Blanco-Melo","year":"2024","unstructured":"Blanco-Melo, D. et al. A novel approach to exploring the dark genome and its application to mapping of the vertebrate virus fossil record. Genome Biol. 25, 120 (2024).","journal-title":"Genome Biol."},{"key":"73380_CR111","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1128\/JVI.74.8.3715-3730.2000","volume":"74","author":"M Tristem","year":"2000","unstructured":"Tristem, M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74, 3715\u20133730 (2000).","journal-title":"J. Virol."},{"key":"73380_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0232-y","volume":"13","author":"L Vargiu","year":"2016","unstructured":"Vargiu, L. et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology 13, 7 (2016).","journal-title":"Retrovirology"},{"key":"73380_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-017-0107-y","volume":"9","author":"KK Kojima","year":"2018","unstructured":"Kojima, K. K. Human transposable elements in Repbase: Genomic footprints from fish to humans. Mob. DNA 9, 2 (2018).","journal-title":"Mob. DNA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73380-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:02:25Z","timestamp":1784595745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73380-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73380"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73380-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6762"}}